Invacare Corporation
IVC · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $741,733 | $872,457 | $850,689 | $927,964 |
| % Growth | -15% | 2.6% | -8.3% | – |
| Cost of Goods Sold | $566,340 | $633,351 | $605,437 | $665,897 |
| Gross Profit | $175,393 | $239,106 | $245,252 | $262,067 |
| % Margin | 23.6% | 27.4% | 28.8% | 28.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $260,061 |
| SG&A Expenses | $226,780 | $232,242 | $236,357 | $260,061 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $226,780 | $232,242 | $236,357 | $260,061 |
| Operating Income | -$69,481 | -$14,812 | $11,327 | -$10,410 |
| % Margin | -9.4% | -1.7% | 1.3% | -1.1% |
| Other Income/Exp. Net | -$17,535 | -$14,884 | -$35,766 | -$46,031 |
| Pre-Tax Income | -$98,001 | -$39,118 | -$24,439 | -$44,025 |
| Tax Expense | $3,070 | $6,445 | $3,841 | $9,302 |
| Net Income | -$101,071 | -$45,563 | -$28,280 | -$53,327 |
| % Margin | -13.6% | -5.2% | -3.3% | -5.7% |
| EPS | -2.77 | -1.29 | -0.82 | -1.59 |
| % Growth | -114.7% | -57.3% | 48.4% | – |
| EPS Diluted | -2.77 | -1.29 | -0.82 | -1.59 |
| Weighted Avg Shares Out | 36,517 | 35,274 | 34,375 | 33,642 |
| Weighted Avg Shares Out Dil | 36,517 | 35,274 | 34,375 | 33,642 |
| Supplemental Information | – | – | – | – |
| Interest Income | -$56 | -$1 | $93 | $429 |
| Interest Expense | $28,520 | $24,306 | $28,499 | $29,076 |
| Depreciation & Amortization | -$10,985 | $16,821 | $21,268 | $24,490 |
| EBITDA | -$80,466 | $2,009 | $25,328 | $2,006 |
| % Margin | -10.8% | 0.2% | 3% | 0.2% |